Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
WB
IF
IHC
WB
Concentration
1 mg/ml
Recomended Dilution
IHC-p: 100-300.Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications.
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from the C-terminal region of human KRAS. AA range:150-189
Subcellular Location
Cell membrane
Cytoplasmic side . Endomembrane system . Cytoplasm, cytosol .
Lipid-anchor
Lipid-anchor .
[Isoform 2B]: Cell membrane
Cytoplasmic side . Endomembrane system . Cytoplasm, cytosol .
Lipid-anchor
Lipid-anchor .
[Isoform 2B]: Cell membrane
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
3845
Observed Band
22kD
Other Name
GTPase KRas (K-Ras 2
Ki-Ras
c-K-ras
c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]
Ki-Ras
c-K-ras
c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]
Background
This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that res